Risedronate for the Treatment of Osteoporosis for People With Spinal Cord Injury

PHASE3CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

January 31, 2009

Study Completion Date

March 31, 2009

Conditions
Osteoporosis
Interventions
DRUG

Risedronate

Trial Locations (1)

M4G 3V9

Toronto Rehab, Lyndhurst Centre, Toronto

All Listed Sponsors
collaborator

The Physicians' Services Incorporated Foundation

OTHER

collaborator

St. Joseph's Health Care London

OTHER

lead

Toronto Rehabilitation Institute

OTHER

NCT00138866 - Risedronate for the Treatment of Osteoporosis for People With Spinal Cord Injury | Biotech Hunter | Biotech Hunter